Pharma firm in storm over 'sub-standard medicines'
A generic pharmaceutical manufacturer has been accused of selling substandard medicines in order to win approval from European drug regulators.
A generic pharmaceutical manufacturer, which has a plant in Ireland and sells into the significant Irish market, has been accused of selling substandard medicines and submitting false data in order to win approval from European drug regulators.
The damaging claims were published in a lengthy feature about Ranbaxy, which has a plant in County Tipperary, in Fortune magazine last weekend.
Fortune published, for the first time, multiple accounts from current and former company insiders, backed...
Subscribe from just €1 for the first month!
All Digital Access + eReader
Unlimited Access for 1 Month
*New subscribers only
€149 For the 1st Year
Unlimited Access for 1 Year
90 Day Pass
Unlimited Access for 2 Years
Get a Business Account for you and your team